Events  Deals  Jobs  NFT NYC 2024 
    Sign in  
 
 
With John Sullivan (MD Equity Research, Leerink Partners), David Wolf (President, Spektron Systems), Vered Caplan (CEO, Orgenesis), Alfred Slanetz (CEO, Geneius), Bill Farley (VP Biz Dev, Sorrento Therapeutics), Deepu Madduri (Medical Oncologist, Mt Sinai Hospital), John Pendergrast (Dir., Heat Biologics), Andrea Bartzen (IMPACTIV BioConsult).
Thu, Oct 25, 2018 @ 06:00 PM   FREE   Splash HQ, 666 3rd Ave
 
     
 
 
              

      
 
Sign up for our awesome New York
Tech Events weekly email newsletter.
   
EVENT DETAILS
The biotech market is buzzing with big-ticket buyouts of companies focused on cell therapies. Why? Consider that the CAR-T cell therapy market alone is expected to grow by 45.6% by 2025. And the CAR-T revolution is just the beginning of a new era in which scientists & emerging biotech companies are developing living drugs to treat all types of diseases.

This event will bring esteemed executives from emerging cell therapy companies together to discuss where the industry is headed & how their companies, individually & collectively, may lead us into the new era. Our moderator will translate this insider foresight into investment insight, helping you evaluate cell therapy companies to capitalize on their success.

#LIVINGDRUGREVOLUTION
 
 
 
 
© 2024 GarysGuide      About    Feedback    Press    Terms